Xtant Medical Says It No Longer Expects To Achieve Its Previously Issued FY26 Guidance; Co. Is Not Providing Revised FY26 Financial Guidance
Benzinga Newsdesk 5 days ago
NewsGuidance
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
2026 Financial GuidanceBased on year-to-date performance, the Company no longer expects to achieve its previously issued full-year 2026 guidance. While the Board of Directors conducts its strategic review process, the
2026 Financial Guidance
Based on year-to-date performance, the Company no longer expects to achieve its previously issued full-year 2026 guidance. While the Board of Directors conducts its strategic review process, the Company is not providing revised full-year 2026 financial guidance. At the same time, as detailed elsewhere in this release, the Board is encouraged by the recent momentum in the Company's core biologics business and remains committed to scaling this franchise throughout the strategic review process.
